Circadia by Dr Pugliese, Inc.
FDA inspection history in Leesport, Pennsylvania, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Leesport, Pennsylvania.
Cited most
Across all Circadia by Dr Pugliese observations on file
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.180(e)(2)General requirements1
- 21 CFR 211.67(b)Equipment cleaning and maintenance1
The complete Circadia by Dr Pugliese file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Leesport, Pennsylvania
One Form 483 · 2022 · 6 observations
Latest: Form 483, Apr 1, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-04-01 | 483 Form 483 | Leesport, Pennsylvania | 6 | $99 |
Investigators on these documents
FEI number 3015538837 · most recent document Apr 1, 2022
About Circadia by Dr Pugliese, Inc.
How many FDA Form 483s has Circadia by Dr Pugliese, Inc. received?
FDA Intel has 1 Form 483 on file for Circadia by Dr Pugliese, Inc.; the most recent is dated Apr 1, 2022.
When was Circadia by Dr Pugliese, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Circadia by Dr Pugliese, Inc. is a Form 483 dated Apr 1, 2022, for the site in Leesport, Pennsylvania.
What did FDA cite at Circadia by Dr Pugliese, Inc.?
The regulations cited most in the observations on file for Circadia by Dr Pugliese, Inc. are 21 CFR 211.100(a) (Written procedures; deviations), 1 time; 21 CFR 211.165(a) (Testing and release for distribution), 1 time; 21 CFR 211.166(a) (Stability testing), 1 time.